Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2017

Sep 8, 2017

33819_dirs_2017-09-07_e6eb6b09-8e5a-4c18-b72a-dba6a287775e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2017-09-06

Reporting Person: Bornstein Yoseph (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-06 Common Stock S 25000 $1.00 Disposed 5245409 Indirect
2017-09-06 Common Stock S 610 $1.08 Disposed 5244799 Indirect
2017-09-06 Common Stock S 20000 $1.01 Disposed 5224799 Indirect

Footnotes

F1: Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.